← United States · Coverage record
US · SEC FORM 4
Veradermics, Inc
MANE · NYSE · CIK 0001827635 · Healthcare · Biotechnology
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
20 Form 4 transaction lines observed in the same window
15 sales · 5 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
—
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2026-02-06 · Averill Madison Master Fund, Ltd.; Averill Master Fund, Ltd.; Cowen Aaron; SUVRETTA CAPITAL MANAGEMENT, LLC.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 4,244,476
- Previous report
- 4,106,974
- Avg daily volume
- 907,033
- Days to cover
- 4.7
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-02-06 | Averill Madison Master Fund, Ltd.; Averill Master Fund, Ltd.; Cowen Aaron; SUVRETTA CAPITAL MANAGEMENT, LLC | Purchase (P) | Common stock, par value $0.00001 per share | 30,521 | USD 36.34 | USD 1,109,056 | SEC filing ↗ |
| 2026-02-05 | CHILDS JOHN W | Purchase (P) | Common Stock | 294,117 | USD 17.00 | USD 4,999,989 | SEC filing ↗ |
| 2026-02-05 | Averill Madison Master Fund, Ltd.; Averill Master Fund, Ltd.; Cowen Aaron; SUVRETTA CAPITAL MANAGEMENT, LLC | Purchase (P) | Common stock, par value $0.00001 per share | 96,200 | USD 37.99 | USD 3,655,079 | SEC filing ↗ |
| 2026-02-05 | Longitude 103.8 East Partners, LLC; Longitude 103.8 East, L.P.; Longitude Capital Partners V, LLC; Longitude Venture Partners V, L.P. | Purchase (P) | Common Stock | 1,075,000 | USD 17.00 | USD 18,275,000 | SEC filing ↗ |
| 2026-02-05 | ENRIGHT PATRICK G | Purchase (P) | Common Stock | 1,075,000 | USD 17.00 | USD 18,275,000 | SEC filing ↗ |
| 2026-02-05 | Coric Vlad | Purchase (P) | Common Stock | 58,823 | USD 17.00 | USD 999,991 | SEC filing ↗ |
| 2026-02-05 | CHILDS JOHN W | Purchase (P) | Common Stock | 294,117 | USD 17.00 | USD 4,999,989 | SEC filing ↗ |
| 2026-02-04 | Averill Madison Master Fund, Ltd.; Averill Master Fund, Ltd.; Cowen Aaron; SUVRETTA CAPITAL MANAGEMENT, LLC | Purchase (P) | Common stock, par value $0.00001 per share | 155,953 | USD 37.05 | USD 5,778,342 | SEC filing ↗ |
Form 4 evidence
60 transaction lines in the latest 365-day window; 60 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-01 | Hollander David | Award / grant (A) | Common Stock | 9,650 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-20 | Averill Madison Master Fund, Ltd.; Averill Master Fund, Ltd.; Cowen Aaron; MONTANOVA CAPITAL, LLC | X (X) | Common stock, par value $0.00001 per share | 300,000 | USD — | USD — | SEC filing ↗ |
| 2026-08-19 | Averill Madison Master Fund, Ltd.; Averill Master Fund, Ltd.; Cowen Aaron; MONTANOVA CAPITAL, LLC | Sale (S) | Common stock, par value $0.00001 per share | 750,000 | USD 107.25 | USD 80,437,500 | SEC filing ↗ |
Show recent Form 4 evidence (23 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-01 | Hollander David | Award / grant (A) | Common Stock | 9,650 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-20 | Averill Madison Master Fund, Ltd.; Averill Master Fund, Ltd.; Cowen Aaron; MONTANOVA CAPITAL, LLC | X (X) | Common stock, par value $0.00001 per share | 300,000 | USD — | USD — | SEC filing ↗ |
| 2026-08-19 | Averill Madison Master Fund, Ltd.; Averill Master Fund, Ltd.; Cowen Aaron; MONTANOVA CAPITAL, LLC | Sale (S) | Common stock, par value $0.00001 per share | 750,000 | USD 107.25 | USD 80,437,500 | SEC filing ↗ |
| 2026-08-17 | Waldman Reid Alexander | Sale (S) | Common Stock | 67,500 | USD 107.86 | USD 7,280,713 | SEC filing ↗ |
| 2026-08-17 | Waldman Reid Alexander | Option exercise / conversion (M) | Common Stock | 3,452 | USD 12.19 | USD 42,080 | SEC filing ↗ |
| 2026-08-17 | Durso Timothy August | Sale (S) | Common Stock | 43,500 | USD 107.82 | USD 4,690,005 | SEC filing ↗ |
| 2026-08-17 | Durso Timothy August | Option exercise / conversion (M) | Common Stock | 3,452 | USD 12.19 | USD 42,080 | SEC filing ↗ |
| 2026-08-12 | CHILDS JOHN W | Sale (S) | Common Stock | 100,000 | USD 107.12 | USD 10,711,700 | SEC filing ↗ |
| 2026-02-06 | Averill Madison Master Fund, Ltd.; Averill Master Fund, Ltd.; Cowen Aaron; SUVRETTA CAPITAL MANAGEMENT, LLC | Purchase (P) | Common stock, par value $0.00001 per share | 30,521 | USD 36.34 | USD 1,109,056 | SEC filing ↗ |
| 2026-02-05 | CHILDS JOHN W | Purchase (P) | Common Stock | 294,117 | USD 17.00 | USD 4,999,989 | SEC filing ↗ |
| 2026-02-05 | Averill Madison Master Fund, Ltd.; Averill Master Fund, Ltd.; Cowen Aaron; SUVRETTA CAPITAL MANAGEMENT, LLC | Purchase (P) | Common stock, par value $0.00001 per share | 96,200 | USD 37.99 | USD 3,655,079 | SEC filing ↗ |
| 2026-02-05 | Waldman Reid Alexander | C (C) | Common Stock | 1,437 | USD — | USD — | SEC filing ↗ |
| 2026-02-05 | Longitude 103.8 East Partners, LLC; Longitude 103.8 East, L.P.; Longitude Capital Partners V, LLC; Longitude Venture Partners V, L.P. | Purchase (P) | Common Stock | 1,075,000 | USD 17.00 | USD 18,275,000 | SEC filing ↗ |
| 2026-02-05 | Longitude 103.8 East Partners, LLC; Longitude 103.8 East, L.P.; Longitude Capital Partners V, LLC; Longitude Venture Partners V, L.P. | C (C) | Common Stock | 2,407,752 | USD — | USD — | SEC filing ↗ |
| 2026-02-05 | Grant-Kels Jane M. | C (C) | Common Stock | 2,455 | USD — | USD — | SEC filing ↗ |
| 2026-02-05 | ENRIGHT PATRICK G | Purchase (P) | Common Stock | 1,075,000 | USD 17.00 | USD 18,275,000 | SEC filing ↗ |
| 2026-02-05 | ENRIGHT PATRICK G | C (C) | Common Stock | 2,407,752 | USD — | USD — | SEC filing ↗ |
| 2026-02-05 | Durso Timothy August | C (C) | Common Stock | 1,473 | USD — | USD — | SEC filing ↗ |
| 2026-02-05 | Coric Vlad | Purchase (P) | Common Stock | 58,823 | USD 17.00 | USD 999,991 | SEC filing ↗ |
| 2026-02-05 | Coric Vlad | C (C) | Common Stock | 377,687 | USD — | USD — | SEC filing ↗ |
| 2026-02-05 | CHILDS JOHN W | Purchase (P) | Common Stock | 294,117 | USD 17.00 | USD 4,999,989 | SEC filing ↗ |
| 2026-02-05 | CHILDS JOHN W | C (C) | Common Stock | 1,907,889 | USD — | USD — | SEC filing ↗ |
| 2026-02-04 | Averill Madison Master Fund, Ltd.; Averill Master Fund, Ltd.; Cowen Aaron; SUVRETTA CAPITAL MANAGEMENT, LLC | Purchase (P) | Common stock, par value $0.00001 per share | 155,953 | USD 37.05 | USD 5,778,342 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | MANE |
| CIK | 0001827635 |
| Sector | Healthcare |
| Industry | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| Exchange | NYSE |
Data coverage
| Local Form 4 history | 60 transaction lines from 2026-02-04 to 2026-09-01 26 P purchase lines · 15 S sale lines · 19 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.